REMISSION EVALUATION BEFORE INTENSIFIED TREATMENT IN LYMPHOMA: IMPACT OF POSITRON EMISSION TOMOGRAPHY (PET) USING FLUORINE-18-FLORO-DEOXYGLUCOSE (FDG) IN THE THERAPEUTIC PRESCRIPTION. MEDICO-ECONOMIC RANDOMISED STUDY: